NO20002631L - Pseudopolymorfe former av 2-[2-[4-(bis(4-fluorfenyl)metyl]-1- piperazinyl]etoksy]eddiksyre dihydroklorid - Google Patents

Pseudopolymorfe former av 2-[2-[4-(bis(4-fluorfenyl)metyl]-1- piperazinyl]etoksy]eddiksyre dihydroklorid

Info

Publication number
NO20002631L
NO20002631L NO20002631A NO20002631A NO20002631L NO 20002631 L NO20002631 L NO 20002631L NO 20002631 A NO20002631 A NO 20002631A NO 20002631 A NO20002631 A NO 20002631A NO 20002631 L NO20002631 L NO 20002631L
Authority
NO
Norway
Prior art keywords
piperazinyl
fluorophenyl
ethoxy
bis
methyl
Prior art date
Application number
NO20002631A
Other languages
English (en)
Other versions
NO20002631D0 (no
NO314692B1 (no
Inventor
Monique Berwaer
Guy Bodson
Michel Deleers
Charles Dogimont
Domenico Fanara
Jacques Timmermans
Original Assignee
Ubc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ubc Sa filed Critical Ubc Sa
Publication of NO20002631L publication Critical patent/NO20002631L/no
Publication of NO20002631D0 publication Critical patent/NO20002631D0/no
Publication of NO314692B1 publication Critical patent/NO314692B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20002631A 1997-11-26 2000-05-23 Pseudopolymorfe former av 2-[2-[4-(bis(4-fluorfenyl)metyl]-1- piperazinyl]etoksy]eddiksyre dihydroklorid, fremgangsmåter for fremstilling avdisse, samt farmasöytisk preparat av dem NO314692B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (en) 1997-11-26 1997-11-26 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
PCT/BE1998/000184 WO1999028310A1 (en) 1997-11-26 1998-11-26 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride

Publications (3)

Publication Number Publication Date
NO20002631L true NO20002631L (no) 2000-05-23
NO20002631D0 NO20002631D0 (no) 2000-05-23
NO314692B1 NO314692B1 (no) 2003-05-05

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002631A NO314692B1 (no) 1997-11-26 2000-05-23 Pseudopolymorfe former av 2-[2-[4-(bis(4-fluorfenyl)metyl]-1- piperazinyl]etoksy]eddiksyre dihydroklorid, fremgangsmåter for fremstilling avdisse, samt farmasöytisk preparat av dem

Country Status (39)

Country Link
US (2) US6262057B1 (no)
EP (2) EP0919550A1 (no)
JP (2) JP3996348B2 (no)
KR (1) KR100557711B1 (no)
CN (1) CN100406448C (no)
AR (1) AR017676A1 (no)
AT (1) ATE203237T1 (no)
AU (1) AU735819B2 (no)
BG (1) BG64155B1 (no)
BR (1) BR9815405A (no)
CA (1) CA2310318C (no)
CO (1) CO4980892A1 (no)
CZ (1) CZ295972B6 (no)
DE (1) DE69801163T2 (no)
DK (1) DK1034171T3 (no)
EG (1) EG23776A (no)
ES (1) ES2161552T3 (no)
GC (1) GC0000094A (no)
GR (1) GR3036702T3 (no)
HU (1) HUP0100343A3 (no)
ID (1) ID24964A (no)
IL (1) IL135544A (no)
MA (1) MA26569A1 (no)
MY (1) MY119653A (no)
NO (1) NO314692B1 (no)
NZ (1) NZ504461A (no)
PE (1) PE134899A1 (no)
PL (1) PL190871B1 (no)
PT (1) PT1034171E (no)
RS (1) RS49904B (no)
RU (1) RU2182575C2 (no)
SI (1) SI20325A (no)
SK (1) SK283237B6 (no)
TN (1) TNSN98214A1 (no)
TR (1) TR200001505T2 (no)
TW (1) TWI225053B (no)
UA (1) UA54568C2 (no)
WO (1) WO1999028310A1 (no)
ZA (1) ZA9810780B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
EP1414460A1 (en) * 2001-07-26 2004-05-06 Ucb, S.A. Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
JP5160018B2 (ja) * 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
US20070185122A1 (en) * 2003-05-28 2007-08-09 Christophe Revirron Use of efletirizine for treating persistent allergic rhinitis
WO2006050909A1 (en) * 2004-11-10 2006-05-18 Ucb Farchim Sa Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
WO2008155777A2 (en) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Process for preparing efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
FI75816C (fi) 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
UA8337A1 (uk) * 1981-02-06 1996-03-29 Бальтес Ежен 2-[4-(дифенілметіл)-1-піперазиніл]-оцтові кислоти або їх аміди, або їх нетоксичні фармацевтично прийняті солі, що проявляють спазмолітичну і антигістамінну активність
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.

Also Published As

Publication number Publication date
MY119653A (en) 2005-06-30
PT1034171E (pt) 2001-11-30
US20010021712A1 (en) 2001-09-13
ES2161552T3 (es) 2001-12-01
PL190871B1 (pl) 2006-02-28
EG23776A (en) 2007-08-08
ZA9810780B (en) 1999-05-31
JP2007224042A (ja) 2007-09-06
SI20325A (sl) 2001-02-28
JP2001524548A (ja) 2001-12-04
IL135544A0 (en) 2001-05-20
RU2182575C2 (ru) 2002-05-20
NZ504461A (en) 2001-06-29
CN1279676A (zh) 2001-01-10
PL340724A1 (en) 2001-02-26
ATE203237T1 (de) 2001-08-15
TWI225053B (en) 2004-12-11
DE69801163D1 (en) 2001-08-23
CA2310318C (en) 2003-10-21
CA2310318A1 (en) 1999-06-10
EP1034171A1 (en) 2000-09-13
US6262057B1 (en) 2001-07-17
KR100557711B1 (ko) 2006-03-07
TR200001505T2 (tr) 2000-09-21
BG64155B1 (bg) 2004-02-27
US6335331B2 (en) 2002-01-01
PE134899A1 (es) 2000-01-11
AR017676A1 (es) 2001-09-12
CZ295972B6 (cs) 2005-12-14
TNSN98214A1 (fr) 2005-03-15
JP3996348B2 (ja) 2007-10-24
BG104424A (en) 2001-01-31
HUP0100343A2 (hu) 2001-07-30
EP0919550A1 (en) 1999-06-02
KR20010032420A (ko) 2001-04-16
NO20002631D0 (no) 2000-05-23
DE69801163T2 (de) 2002-03-28
BR9815405A (pt) 2000-10-10
DK1034171T3 (da) 2001-11-05
SK5942000A3 (en) 2000-10-09
AU735819B2 (en) 2001-07-19
GR3036702T3 (en) 2001-12-31
HUP0100343A3 (en) 2001-09-28
WO1999028310A1 (en) 1999-06-10
EP1034171B1 (en) 2001-07-18
SK283237B6 (sk) 2003-04-01
YU31600A (sh) 2002-03-18
RS49904B (sr) 2008-08-07
CO4980892A1 (es) 2000-11-27
CZ20001787A3 (cs) 2000-09-13
IL135544A (en) 2004-02-08
AU1327799A (en) 1999-06-16
MA26569A1 (fr) 2004-12-20
GC0000094A (en) 2005-06-29
ID24964A (id) 2000-08-31
UA54568C2 (uk) 2003-03-17
CN100406448C (zh) 2008-07-30
NO314692B1 (no) 2003-05-05

Similar Documents

Publication Publication Date Title
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
NO20005673D0 (no) Heterocykliske inhibitorer av P38
ATE219067T1 (de) Substituierte (2-(1-piperazinyl)ethoxy)methyl- derivate
DK1237854T3 (da) Pulveriseret form af (S)-2-ethoxy-3-[4-(2-(4-methan sulfonyloxyphenyl)ethoxy)phenyl]propanonsyre
AU2002237684A1 (en) Methods of synthesizing and using derivatives of (2-(2-aminoethoxy)ethoxy) acetic acid
NO20002631D0 (no) Pseudopolymorfe former av 2-[2-[4-(bis(4-fluorfenyl)metyl]-1- piperazinyl]etoksy]eddiksyre dihydroklorid
PT1246817E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo
KR970707115A (ko) 플루오로퀴놀론의 물리적으로 안정한 신규한 고체 형태(a new physically stable solid form of a fluoroquinolone)
DK1055658T3 (da) Fremstilling af cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphtalen-1-yl)phenoxy]ethyl-pyrrolidin
NO971583D0 (no) Fremgangsmåte for fremstilling av 2-£2-£4-£4-klorofenyl)fenylmetyl|-1-piperazinyl|etoksy|eddiksyre og deres salter
NO20020059D0 (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO992268D0 (no) N-bundne sulfonamider av heterocykliske tioestere
BR9603916A (pt) Derivados de ácido 2-(pirazolióxi-pirimidin-5-il) acético
DE60037197D1 (de) Verwendung funktioneller oraler präparate
NO995841L (no) Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2- fenylpropionsyre-derivater
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO994108D0 (no) Fremgangsmåte ved fremstilling av 4H-4-okso-kinolizin-3-karboksylsyrederivater
DE69907769D1 (de) Verfahren zur Herstellung von 2-Sulfonylpyridinderivaten und 2-( (2-Pyridyl)methyl)thio)-1H-benzimidazolderivaten
NO20003216D0 (no) Nytt fosfatsalt av isopropylmetyl-(2-(3-n- propoksyfenoksy)etyl)amin
IL176734A (en) Method for the preparation of 1 - (6 - methylpyridine - 3 - yl) - 2 - [4 - (methylsulfonyl) phenyl] ethanone